Carol-Ann Ohmstede
Nessuna posizione attualmente
Profilo
Carol-Ann Ohmstede joined Trimeris, Inc. in 1998 as Vice President of Project Planning and was promoted to Vice President of Corporate Alliances and Project Planning in 2001.
Prior to joining Trimeris, she held various positions in the Research and Development Division of Burroughs Wellcome, Inc. and Glaxo Wellcome.
Dr. Ohmstede received a BA and a PhD in Biochemistry from the University of South Florida College of Medicine.
Precedenti posizioni note di Carol-Ann Ohmstede
| Società | Posizione | Fine |
|---|---|---|
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Formazione di Carol-Ann Ohmstede
| University of South Florida | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
- Borsa valori
- Insiders
- Carol-Ann Ohmstede
